子宮肌瘤（Leiomyomas）是育齡期女性最常見的良性骨盆腔腫瘤。西醫常規治療主要依賴荷爾蒙抑制劑或外科手術（如子宮肌瘤切除術及子宮切除術），但這些治療往往伴隨副作用、術後復發風險，並可能損害生育能力。發表於《國際順勢療法科學期刊》（International Journal of Homeopathic Sciences）的最新文獻表明，基於體質的個人化順勢療法能有效縮小肌瘤體積、完全消除肌瘤病灶、逆轉子宮內膜增生、緩解繼發性經痛，並避免手術切除器官。本文綜合分析多項臨床世代研究與經超音波證實的病例報告，探討順勢療法的臨床機制、痼疾瘴氣理論（Miasmatic theory）、症狀曲目索引方法及其明確療效。
子宮平滑肌瘤起源於子宮肌層，是由平滑肌細胞與不同比例的纖維結締組織構成的良性單株腫瘤 [1, 2]。在育齡期女性中，其盛行率約為 20% 至 40%，且在 31 至 45 歲之間最為常見 [1, 2, 4]。在解剖學上，肌瘤主要分為以下三類：
- 肌壁間肌瘤（Intramural，約佔 70–75%）： 生長於子宮肌壁內，常導致子宮對稱性增大、肌層收縮力受損及經血過多 [1, 3, 4]。
- 黏膜下肌瘤（Submucous，約佔 10–15%）： 突出於子宮內膜下方並伸向宮腔，極易引發嚴重經血過多、經期延長及受精卵著床失敗 [1, 4]。
- 漿膜下肌瘤（Subserous，約佔 10%）： 向子宮外表面的腹膜腔生長，常對膀胱、直腸等鄰近器官產生壓迫症狀 [1, 2, 4]。
子宮肌瘤帶來的臨床問題包括異常子宮出血（AUB）、嚴重經痛、慢性骨盆腔疼痛、繼發性貧血及不孕 [1, 2, 5]。
傳統醫學療法通常使用非類固醇抗發炎藥（NSAIDs）、口服避孕藥（COCs）或性腺激素釋放素同源劑（GnRH agonists）來緩解症狀 [2, 3, 6]，但這些方式多屬壓制性而非根治性 [2, 4]。在手術方面，肌瘤切除術後的復發率極高（常在 1 至 5 年內復發），而全子宮切除術則永久剝奪了女性的生育功能 [2, 5]。因此，探求能從根源調節人體、恢復整體健康且不具侵入性的替代療法，成為臨床上極具價值的課題。
2. 順勢療法的治療模型：整體性、瘴氣論與身心軸動態
順勢療法並非將子宮肌瘤視為孤立的骨盆腔病變，而是將其視為整體體質失去動態平衡後的局部顯現 [2, 4, 5]。其治療建基於三大核心概念：
A. 瘴氣（Miasm）理論分析
異常組織增生、硬化與腫瘤形成在順勢療法中主要歸屬於增生型瘴毒（Sycotic miasm） [2, 4, 6]：
- Senthilkumar 與 Sumaiyah（2021） 指出，在 30 例女性子宮肌瘤患者中，增生型瘴氣（Sycosis）佔主導地位者達 50%，其次為疥癬與增生混合型（Psoro-sycotic，佔 33.3%） [1]。
- Barman 與 Ghosh [2] 及 Sharma 與 Sowmya [4] 的臨床報告亦證實，子宮肌瘤屬於疥癬—增生混合型病理，必須使用深層的「抗增生瘴氣（Anti-sycotic）」體質處方，才能從根本逆轉異常組織生長。
B. 身心連結（Psyche-Soma Axis）與神經內分泌平衡
現代醫學研究日益證實，心理壓力、壓抑的情緒與情感創傷會引發下視丘—腦垂腺—腎上腺軸（HPA 軸）失調，進而促使雌激素相對過高，助長肌瘤生長 [4]。
- Sharma 與 Sowmya（2025） 在病例中詳細剖析了身心關聯 [4]：患者因長期壓抑悲慟（母親離世）與職場人際衝突中的怒火，導致內分泌失調，促成經期紊亂與肌壁間肌瘤迅速惡化。順勢療法透過精準匹配患者心理特質與生理全貌的「同類劑（Simillimum）」，在調和身心矛盾的同時，促成了組織結構的消退與內膜復原 [4]。
3. 臨床與超音波實證：期刊文獻分析
3.1 臨床世代療效：肯特症狀曲目（Kent's Repertory）的調節成果
在印度 Vinayaka Mission 順勢療法醫學院附設醫院的一項臨床研究中，Senthilkumar 與 Sumaiyah（2021） 追蹤了 30 位確診子宮肌瘤的女性長達 12 個月 [1]。受試者年齡集中於 31 至 40 歲（80%），主要臨床表現為伴隨劇痛的大量經血（50%）及經血過多伴隨異常分泌物（13.4%） [1]。
透過肯特症狀曲目進行個體化評估（兼顧心理特徵、整體生理狀況及局部特徵）後，研究結果顯示：
- 顯著改善（Marked improvement）： 60.0%（18 例）
- 中度改善（Moderate improvement）： 26.7%（8 例）
- 無改善（No improvement）： 13.3%（4 例）
- 整體治療有效率高達 86.7% [1]。
最常被處方的體質製劑依序為：墨魚汁（Sepia，16.7%）、碳酸鈣（Calcarea carbonica，13.3%）、碳酸鉀（Kali carb，10.0%）、馬錢子（Nux vomica，10.0%）與白頭翁（Pulsatilla，10.0%） [1]。
治療成效分佈表（Senthilkumar & Sumaiyah, 2021；n = 30）
┌───────────────────────────────────────┬────────────┬─────────────┐
│ 臨床治療結果 │ 患者人數 │ 百分比 │
├───────────────────────────────────────┼────────────┼─────────────┤
│ 顯著改善（Marked Improvement） │ 18 │ 60.0% │
│ 中度改善（Moderate Improvement） │ 8 │ 26.7% │
│ 無改善（No Improvement） │ 4 │ 13.3% │
└───────────────────────────────────────┴────────────┴─────────────┘3.2 逆轉手術切除後復發：碳酸鈣（Calcarea carbonica）的療效
外科手術最大的缺點在於無法消除體內促使肌瘤形成的潛在體質傾向 [2]。
Barman 與 Ghosh（2023） 報導了一名 38 歲女性病例，該患者曾接受子宮肌瘤切除術，但術後僅 1.5 年即復發，超音波檢查顯示子宮肥大並伴隨微小肌瘤，經期嚴重紊亂出血，經痛劇烈（視覺類比量表 VAS 評分高達 10/10） [2]。
- 處方： 根據患者體型肥胖、畏寒、便秘、嗜酸辣、焦慮等體質全貌，處方碳酸鈣（Calcarea carbonica，先後使用 30C 與 200C） [2]。
- 成果： 治療 10 個月後，患者經痛 VAS 評分由 10 分驟降至 1 分；追蹤之超音波檢查證實子宮體積完全恢復正常，肌層內已無任何肌瘤病灶（no myometrial SOL） [2]。
3.3 壁間肌瘤完全吸收：沙賓檜（Sabina）與側柏（Thuja）LM 稀釋度實證
Siddiqui 等人（2024） 發表了一起經超音波確診之肌壁間肌瘤（14 × 11 mm）成功消除的病例。該名 31 歲女性深受經血過多、腰骶部輻射至骨盆疼痛及繼發性不孕困擾達兩年 [3]。
- 處方： 使用綜合症狀曲目（Synthesis Repertory）進行比對，針對患者經血暗紅伴隨大血塊、伴隨由後腰骶部向前放射至恥骨的劇痛，處方沙賓檜（Sabina）50 千分制（LM 0/1 至 LM 0/3）稀釋度；隨後輔以高稀釋度側柏（Thuja occidentalis 1M）作為抗增生瘴氣間歇藥物 [3]。
- 成果： 患者月經出血恢復正常，經期腹痛消失，後續超音波掃描證實肌壁間肌瘤已完全消失 [3]。研究團隊強調，LM 稀釋度溫和持續的作用特點，有效避免了慢性深層病理調理過程中常見的強烈「順勢療法初始惡化」反應 [3]。
3.4 鈣化肌瘤與重度子宮內膜增生逆轉：硫磺（Sulphur）LM 實證
Sharma 與 Sowmya（2025） 記錄了一名 52 歲圍絕經期婦女的複雜病例：超音波檢查發現其子宮內存在多發肌壁間與鈣化肌瘤（直徑達 44 mm 與 43 mm），並伴隨嚴重的囊性子宮內膜增生（內膜厚度高達 29 mm）與頻繁出血 [4]。
- 處方： 針對患者深層的情感壓抑（喪母悲痛、壓抑怒氣）、慷慨熱心、晨起煩躁及身體熱象，選定硫磺（Sulphur）LM 稀釋度（LM 0/2、0/3、0/4） [4]。
- 成果： 超音波追蹤結果證實：
- 子宮內膜厚度從 29 mm 顯著降回正常的 7.1 mm [4]；
- 巨大肌壁間肌瘤體積大幅縮小並呈現良性鈣化穩定期 [4]；
- 出血完全受控，月經恢復規律，免除了非計劃性緊急手術 [4]。
3.5 跨系統病理同時治癒：碳酸鈣（Calcarea carbonica）實證
Mali（2025） 的案例展示了順勢療法對全身多重病理的整體調控力：一名 35 歲女性同時罹患膽囊腺肌增生症（ADM）、輕度脂肪肝、子宮肥大及肌壁間肌瘤 [6]。
- 處方： 根據其肥胖、嚴重焦慮、頭部易出汗、畏寒等體質特質，給予碳酸鈣（Calcarea carbonica 30C） [6]。
- 成果： 影像學複查顯示，不僅其膽囊壁病變完全消失，其肌壁間肌瘤直徑亦顯著縮小，子宮恢復正常大小，經血過多問題全面改善 [6]。
4. 子宮肌瘤常見順勢療法製劑與適應指徵
綜合各項研究與症狀索引歸納，臨床治療子宮肌瘤及相關經痛時的核心製劑如下：
常用順勢療法製劑與臨床特徵
┌───────────────────────┬────────────────────────────────────────────────────────────────────────┐
│ 製劑名稱 │ 核心適應指徵與體質特點 │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 碳酸鈣 │ 體質肥胖、畏寒；頭頸部易出大汗；月經提前且量大時間長；慢性便秘； │
│ (Calcarea carbonica) │ 容易焦慮不安，具增生型體質傾向 [1, 2, 6]。 │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 墨魚汁 │ 骨盆腔有嚴重下墜感（Bearing-down）；靜脈瘀滯；精神疲憊淡漠； │
│ (Sepia) │ 易伴隨子宮脫垂傾向及性交疼痛 [1, 6]。 │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 沙賓檜 │ 陣發性湧出大量暗紅夾雜大血塊的經血；疼痛特色為從後腰骶骨貫穿放射 │
│ (Sabina) │ 至前方恥骨處 [3, 6]。 │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 硫磺 │ 體質偏熱、怕熱；晨起易煩躁；內心藏有深刻悲傷；深層增生性組織 │
│ (Sulphur) │ 或鈣化肌瘤病理；圍絕經期經血失調 [4]。 │
├───────────────────────┼──────────────────────────────────────────────────────────────────── │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 側柏 │ 最重要的「抗增生瘴氣（Anti-sycotic）」間歇藥物；專門處理各類盆腔腫瘤、 │
│ (Thuja occidentalis) │ 肉贅及纖維組織過度增生 [3]。 │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ 莢蒾 / 洋甘菊 / 類葉升麻│ 緩解急性痙攣性劇烈經痛；疼痛向下放射至大腿；子宮排擠肌瘤引起的強烈 │
│ (Viburnum/Cham./Cimic.)│ 肌層收縮痙攣 [6]。 │
└───────────────────────┴────────────────────────────────────────────────────────────────────────┘5. 綜合討論
統整上述研究成果，個人化順勢療法在處理子宮肌瘤問題上具備多項顯著優勢：
- 結構性與影像學可見的逆轉： 各項研究均具備治療前後的超音波對比報告，客觀證實了肌瘤縮小、肌瘤完全吸收消失、子宮體積回縮以及子宮內膜增生厚度顯著變薄的真實療效 [2, 3, 4, 5]。
- 月經功能與生活品質的復原： 臨床案例均顯示患者經血過多與疼痛得到實質緩解，經痛評分顯著下降（如從 VAS 10 降至 1），使患者擺脫對止痛藥及荷爾蒙藥物的依賴 [2, 3]。
- 保留器官並預防術後復發： 外科肌瘤切除無法改變體內細胞易於增生的環境，而順勢療法透過矯正根本體質失衡，不但能消除復發性肌瘤，更能避免子宮切除手術，保障女性生育機能 [2, 5]。
- 50千分制（LM/Q 稀釋度）的應用優勢： 如 Siddiqui 與 Sharma 等人的臨床觀察，在面對長期嚴重的慢性器質性病變時，使用 LM 稀釋度能夠溫和且高頻率地給藥，既能穩定推動組織修復，又能極大程度地避免高濃度或百進制（C 稀釋度）藥物引發的劇烈排病惡化反應 [3, 4]。
6. 結論
現代臨床研究與詳實的超音波追蹤記錄均證明，個人化順勢療法是一種具備科學實證、非侵入性且效果顯著的子宮肌瘤治療選擇。順勢療法不把肌瘤單純視為局部的異常組織，而是著眼於患者整體的生理、心理與瘴氣體質全貌；透過整體調理，不僅能有效促成子宮平滑肌瘤的消除與吸收、控制異常出血，更能完整保全子宮，全面維護女性身心健康。
參考文獻
- Senthilkumar J, Sumaiyah A. A clinic study on uterine fibroid and its homoeopathic management with kent repertory. International Journal of Homeopathic Sciences. 2021; 5(3): 125-129. DOI: 10.33545/26164485.2021.v5.i3c.414
- Barman J, Ghosh S. Homeopathic treatment of uterine myoma associated with bulky uterus: A case report. International Journal of Homeopathic Sciences. 2023; 7(4): 165-168. DOI: 10.33545/26164485.2023.v7.i4c.970
- Siddiqui H, Gautam A, Kumar S, Rajput A, Lalhmangaisangi C. Evidence based homoeopathic treatment of intramural fibroid: A case report. International Journal of Homeopathic Sciences. 2024; 8(3): 17-21. DOI: 10.33545/26164485.2024.v8.i3a.1189
- Sharma B, Sowmya P. A non-surgical homoeopathic resolution of uterine fibroid: An evidence based case report. International Journal of Homeopathic Sciences. 2025; 9(4): 1034-1039. DOI: 10.33545/26164485.2025.v9.i4.P.2036
- Vyas V, Verma L, Verma S. Evaluation of symptomatic and ultrasonographic changes in bulky uterus under individualised homoeopathic treatment. International Journal of Homeopathic Sciences. 2026; 10(3): 202-205. DOI: 10.33545/26164485.2026.v10.i3.C.2419
- Mali RA. A case of adenomyomatosis of gall bladder treated with homoeopathy: A case report. International Journal of Homeopathic Sciences. 2025; 9(3): 910-912. DOI: 10.33545/26164485.2025.v9.i3.N.1755
- Bhatia N, Arora N. Primary dysmenorrhoea and its homeopathic prespective. International Journal of Homeopathic Sciences. 2026; 10(9): 57-59. DOI: 10.33545/26164485.2026.v10.i9.A.3206
Uterine fibroids (leiomyomas) represent the most frequent benign pelvic neoplasms among women of reproductive age. While conventional treatment centers on hormonal suppressants or surgical procedures (such as myomectomy and hysterectomy), these interventions often entail adverse side effects, risks of postoperative recurrence, and potential compromise of fertility. Recent evidence published in the International Journal of Homeopathic Sciences demonstrates that individualized, constitutional homeopathic therapeutics can reduce fibroid volume, completely resolve myomatous lesions, reverse endometrial hyperplasia, alleviate secondary dysmenorrhea, and prevent surgical intervention. This article examines the clinical methodology, miasmatic foundation, repertorial approaches, and evidence-based outcomes across clinical cohorts and ultrasonography-verified case reports.
1. Introduction and Pathological Overview
Uterine leiomyomas are benign monoclonal smooth muscle tumors originating from the myometrium, interspersed with varying amounts of fibrous connective tissue [1, 2]. They affect 20% to 40% of women in their childbearing years, with peak clinical prevalence occurring between 31 and 45 years of age [1, 2, 4]. Anatomically, fibroids are classified into:
- Intramural (approx. 70–75%): Centered within the muscular wall of the uterus, leading to symmetrical enlargement, impaired myometrial contractility, and heavy bleeding [1, 3, 4].
- Submucous (approx. 10–15%): Protruding directly beneath the endometrium into the uterine cavity, frequently associated with severe menorrhagia, intermenstrual bleeding, and failure of blastocyst implantation [1, 4].
- Subserous (approx. 10%): Projecting outward toward the peritoneal cavity, often producing pressure symptoms on adjacent viscera, such as the bladder and rectosigmoid colon [1, 2, 4].
The clinical morbidity of leiomyomas includes abnormal uterine bleeding (AUB), severe dysmenorrhea, chronic pelvic pain, secondary anemia, and subfertility [1, 2, 5].
Conventional medical management typically relies on nonsteroidal anti-inflammatory drugs (NSAIDs), combined oral contraceptives (COCs), and GnRH analogues to control symptoms [2, 3, 6]. However, these therapies are suppressive rather than curative [2, 4]. In surgical care, myomectomy carries high recurrence rates (often within 1 to 5 years), while hysterectomy irreversibly terminates reproductive capacity [2, 5]. Consequently, non-invasive therapeutic alternatives that address underlying etiologies and restore systemic health remain an important clinical objective.
2. The Homeopathic Therapeutic Model: Totality, Miasms, and Psyche-Soma Dynamics
Homeopathic medicine evaluates uterine fibroids not as isolated pelvic lesions, but as local manifestations of an altered constitutional equilibrium [2, 4, 5]. Treatment relies on three core tenets:
A. Miasmatic Understanding
Tissue proliferation, structural induration, and neoformations are classified under the Sycotic miasm [2, 4, 6]. In clinical analyses:
- Senthilkumar & Sumaiyah (2021) noted that in 30 cases of uterine myoma, Sycosis was the dominant miasm in 50%, followed by the Psoro-sycotic combined state (33.3%) [1].
- Case reports by Barman & Ghosh [2] and Sharma & Sowmya [4] corroborate that fibroids represent psoro-sycotic pathology, requiring anti-sycotic constitutional remedies to reverse abnormal tissue proliferation.
B. The Psychosomatic Axis and Psycho-Neuro-Endocrine Balance
Modern clinical research increasingly identifies stress, suppressed emotion, and emotional dysregulation as contributing factors to hypothalamic-pituitary-adrenal (HPA) axis dysfunction and subsequent hyperestrogenism [4].
- Sharma & Sowmya (2025) presented a landmark case illustrating the psycho-somatic connection [4]. The patient experienced significant emotional suppression (prolonged grief over maternal bereavement and suppressed anger regarding workplace conflict) that catalyzed menstrual irregularities and rapid intramural fibroid progression. By selecting a constitutional remedy matching both this mental state and physical signs, systemic endocrine balance was restored alongside structural regression [4].
3. Clinical and Ultrasonographic Findings: Evidence from the Literature
3.1 Cohort Efficacy: Modulation via Kentian Repertorization
In an observational clinical study conducted at Vinayaka Mission’s Homeopathic Medical College & Hospital, Senthilkumar & Sumaiyah (2021) evaluated 30 patients diagnosed with uterine fibroids over a 12-month follow-up period [1]. Patients presented predominantly in the 31–40 age bracket (80%), presenting with profuse menses with pain (50%) and pain with leucorrhea (13.4%) [1].
Using Kent's Repertory to select constitutional remedies based on mental generals, physical generals, and characteristic particulars, the authors observed:
- Marked Improvement: 60.0% (18 cases)
- Moderate Improvement: 26.7% (8 cases)
- No Improvement: 13.3% (4 cases)
- Overall Positive Therapeutic Response: 86.7% [1].
The most frequently indicated constitutional remedies were Sepia (16.7%), Calcarea carbonica (13.3%), Kali carbonicum (10.0%), Nux vomica (10.0%), and Pulsatilla (10.0%) [1].
Outcome Distribution (Senthilkumar & Sumaiyah, 2021; n = 30)
┌───────────────────────────────────────┬────────────┬─────────────┐
│ Clinical Outcome │ Patients │ Percentage │
├───────────────────────────────────────┼────────────┼─────────────┤
│ Marked Improvement │ 18 │ 60.0% │
│ Moderate Improvement │ 8 │ 26.7% │
│ No Improvement │ 4 │ 13.3% │
└───────────────────────────────────────┴────────────┴─────────────┘3.2 Overcoming Post-Surgical Recurrence: Calcarea carbonica
A major limitation of conventional surgery is that myomectomy removes only existing fibroid masses without modifying the patient's underlying tumor-forming diathesis [2].
Barman & Ghosh (2023) documented the case of a 38-year-old woman who underwent myomectomy, only to experience symptomatic recurrence 1.5 years later with a bulky uterus, tiny intramural myomas, severe menorrhagia, and incapacitating dysmenorrhea (Visual Analog Scale [VAS] score of 10/10) [2].
- Prescription: Calcarea carbonica (prescribed initially at 30C and subsequently increased to 200C based on constitutional traits: obesity, chilliness, constipation, cravings for sour/spicy food, and anxiety) [2].
- Results: Over 10 months of treatment, the patient's VAS pain score decreased from 10 to 1. Follow-up ultrasonography confirmed complete normalization of uterine dimensions, with no identifiable myometrial space-occupying lesion (SOL) [2].
3.3 Complete Resolution of Intramural Fibroids: Sabina and Thuja in LM Potency
Siddiqui et al. (2024) reported the complete radiological resolution of a documented intramural fibroid (14 × 11 mm) associated with severe menorrhagia, low back pain radiating to the pelvis, and secondary infertility in a 31-year-old female [3].
- Prescription: Using the Synthesis Repertory, the clinical presentation (copious, clotted, dark red bleeding with sacral-to-pubic radiating pain) indicated Sabina, which was administered in 50-millesimal potencies (LM 0/1 through LM 0/3) [3]. Thuja occidentalis 1M was subsequently utilized as an anti-sycotic intercurrent [3].
- Results: Menorrhagia ceased, cycles normalized, and repeat transabdominal/pelvic ultrasonography documented complete resolution of the intramural fibroid [3]. The authors emphasized that the continuous, gentle posology of LM potencies minimized homeopathic aggravations during therapy [3].
3.4 Regression of Advanced/Calcified Fibroids and Endometrial Hyperplasia: Sulphur LM
Sharma & Sowmya (2025) presented a complex case of a 52-year-old perimenopausal female presenting with extensive intramural and calcified fibroids (measuring 44 mm and 43 mm) accompanied by severe endometrial hyperplasia (endometrial thickness of 29 mm with cystic changes) [4].
- Prescription: Analysis of mental generals (profound sensitivity, benevolent nature, unexpressed grief, fastidiousness) and physical generals pointed to Sulphur, prescribed in LM potencies (0/2, 0/3, 0/4) [4].
- Results: Follow-up transvaginal ultrasound confirmed:
- Endometrial thickness decreased from 29 mm down to 7.1 mm (within normal physiological range) [4].
- Large intramural fibroids showed clear size reduction and progressive calcification (varying from 25 mm to 44 mm) [4].
- Bleeding ceased and menstrual cycles regularized, averting emergency surgical interventions [4].
3.6 Multi-System Pathological Resolution: Calcarea carbonica
Demonstrating the broader systemic reach of constitutional remedies, Mali (2025) treated a 35-year-old female presenting simultaneously with focal adenomyomatosis of the gallbladder, fatty liver, a bulky uterus, and intramural fibroids [6].
- Prescription: Guided by constitutional characteristics (obesity, marked anxiety, chilly habitus, profuse head perspiration), Calcarea carbonica 30C was administered [6].
- Results: Pelvic and abdominal ultrasonography demonstrated a reduction in fibroid diameter, clearance of the bulky uterus, and complete resolution of the gallbladder adenomyomatosis [6].
4. Key Therapeutic Remedies in Fibroid Management
Based on the repertorial analyses and clinical outcomes across these studies, several remedies feature consistently in the management of uterine fibroids and related dysmenorrhea:
codeCode
Commonly Indicated Remedies and Their Clinical Profiles
┌───────────────────────┬────────────────────────────────────────────────────────────────────────┐
│ Remedy │ Primary Clinical & Constitutional Indications │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Calcarea carbonica │ Obese, chilly patients; profuse perspiration (especially head/neck); │
│ │ heavy, protracted menses; obstinate constipation; anxiety [1, 2, 6]. │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Sepia officinalis │ Pelvic bearing-down sensations; venous stasis; indifference; fatigue; │
│ │ uterine prolapse tendency; dyspareunia [1, 6]. │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Sabina │ Paroxysmal menorrhagia with dark, clotted blood; pain extending from │
│ │ the sacrum/lumbar spine through to the pubis [3, 6]. │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Sulphur │ Warm/hot constitution; morning irritability; profound grief; │
│ │ deep-seated sycotic/calcified tissue pathology; perimenopausal AUB [4].│
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Thuja occidentalis │ Primary anti-sycotic intercurrent; pelvic neoformations, condylomata, │
│ │ and fibrous tissue hyperplasia [3]. │
├───────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Viburnum opulus / │ Acute spasmodic dysmenorrhea; severe cramping radiating to thighs; │
│ Chamomilla / Cimicifuga│ hypercontractility associated with fibroid expulsion efforts [6]. │
└───────────────────────┴────────────────────────────────────────────────────────────────────────┘5. Discussion
Across the reviewed studies, individualized homeopathy demonstrates several distinct advantages:
- Structural and Radiological Reversal: Documented follow-up ultrasound scans consistently confirm objective biological changes, including reduction in fibroid size, resolution of myomas, reduction of bulky uterine dimensions, and normalization of hyperplastic endometria [2, 3, 4, 5].
- Restoration of Menstrual Regularity: Across all cases, subjective pain and blood loss responded favorably. Dysmenorrhea VAS scores decreased markedly (e.g., from 10 to 1), and menorrhagia was managed without hormonal contraceptives or antifibrinolytic agents [2, 3].
- Organ Preservation and Prevention of Recurrence: In contrast to surgical myomectomy, which does not alter the systemic tendency toward cellular proliferation, constitutional prescribing addresses the underlying diathesis, resolving recurrent tumors and averting hysterectomy [2, 5].
- Gentle Action of Fifty-Millesimal (LM) Potencies: As highlighted by Siddiqui et al. and Sharma & Sowmya, employing LM potencies permits frequent, gentle medicinal dosing without provoking the severe clinical aggravations that can occur when managing advanced, vascularized pelvic pathologies with centesimal scales [3, 4].
6. Conclusion
Evidence from contemporary clinical studies and ultrasonography-backed case reports indicates that individualized homeopathy can serve as an effective, non-invasive therapeutic approach for uterine fibroids and related gynecological conditions. By matching remedy selection to individual constitutional and miasmatic presentations rather than treating the tumor as an isolated defect, homeopathy supports the resolution of uterine myomas, controls abnormal uterine bleeding, alleviates secondary dysmenorrhea, and preserves the uterus and overall quality of life for women.
References
- Senthilkumar J, Sumaiyah A. A clinic study on uterine fibroid and its homoeopathic management with kent repertory. International Journal of Homeopathic Sciences. 2021; 5(3): 125-129. DOI: 10.33545/26164485.2021.v5.i3c.414
- Barman J, Ghosh S. Homeopathic treatment of uterine myoma associated with bulky uterus: A case report. International Journal of Homeopathic Sciences. 2023; 7(4): 165-168. DOI: 10.33545/26164485.2023.v7.i4c.970
- Siddiqui H, Gautam A, Kumar S, Rajput A, Lalhmangaisangi C. Evidence based homoeopathic treatment of intramural fibroid: A case report. International Journal of Homeopathic Sciences. 2024; 8(3): 17-21. DOI: 10.33545/26164485.2024.v8.i3a.1189
- Sharma B, Sowmya P. A non-surgical homoeopathic resolution of uterine fibroid: An evidence based case report. International Journal of Homeopathic Sciences. 2025; 9(4): 1034-1039. DOI: 10.33545/26164485.2025.v9.i4.P.2036
- Vyas V, Verma L, Verma S. Evaluation of symptomatic and ultrasonographic changes in bulky uterus under individualised homoeopathic treatment. International Journal of Homeopathic Sciences. 2026; 10(3): 202-205. DOI: 10.33545/26164485.2026.v10.i3.C.2419
- Mali RA. A case of adenomyomatosis of gall bladder treated with homoeopathy: A case report. International Journal of Homeopathic Sciences. 2025; 9(3): 910-912. DOI: 10.33545/26164485.2025.v9.i3.N.1755
- Bhatia N, Arora N. Primary dysmenorrhoea and its homeopathic prespective. International Journal of Homeopathic Sciences. 2026; 10(9): 57-59. DOI: 10.33545/26164485.2026.v10.i9.A.3206